The Drug Enforcement Administration (DEA) is making progress on the legalization of a cocaine derivative, which researchers have found useful in the differential diagnosis of Parkinson’s disease (PD) and tremor syndromes.

In a Federal Register filing published Monday, the administration wrote that the cocaine derivative [18F]FP-CIT is a “diagnostic substance that is used in assisting the evaluation of adult patients with suspected Parkinsonian syndromes” and does not meet the requirements “for inclusion in any schedule” and is therefore being removed “from control under the CSA.”

About a year ago, the DEA announced plans to deschedule this controlled substance which is derived from cocaine. The move came nearly three years after the agency obtained a petition for the policy change.

The DEA published a notice in the Federal Register revealing that [18 F]FP-CIT is “a diagnostic substance that is used in assisting the evaluation of adult patients with suspected Parkinsonian syndromes” and is used in …

Full story available on Benzinga.com